epcore cll-1: phase i trial of epcoritamab in r/r cll
Published 2 years ago • 336 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:17
epcore cll-1: epcoritamab in patients with r/r cll & richter's transformation
-
1:09
early results from epcore cll-1 trial: subcutaneous epcoritamab in patients with richter’s syndrome
-
3:02
euplagia-1: phase i trial of glpg5201, a cd19 car-t product, in r/r cll and richter's transformation
-
0:45
key trials in cll and designing a concept for treatment
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
2:49
results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml
-
1:02:10
what is cll? - diagnosis and treatment
-
5:00
venetoclax-obinutuzumab is superior to chemoimmunotherapy in frontline cll: updates from gaia/cll13
-
12:33
3mensio ct pre-case planning: valve-in-valve tavr in epic/biocor
-
1:01
cll resistance mechanisms in the era of novel agents
-
2:25
update from murano trial: venetoclax-rituximab leads to slower clonal growth rate in cll
-
1:06
phase ib/ii study of viro-t-cell in patients with r/r cml infection after allosct
-
1:36
using genomics to predict cll progression
-
1:29
the importance of treatment sequencing in cll
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
0:56
the current treatment landscape in cll
-
4:31
sequence of administration of ibrutinib with obinutuzumab in r/r cll patients
-
3:13
selection for time-limited & continuous therapy in cll
-
1:25
the management of cll in italy
-
1:02
investigating lava-051 in r/r myeloma and cll: pharmacodynamic and early clinical cata
-
1:28
the future of cll treatment
-
2:05
in-vivo modeling of cll and richter's transformation